Skip to main content
Equibles
LYEL $9.48 +0.69%
LYEL logo
LYEL · Lyell Immunopharma, Inc.
Track LYEL — free

Use LYEL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LYEL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.48 +0.07 (+0.69%)
Russell 2000 member Rebalance outlook locked
Market Cap
$230.59M
Shares
24.51M
Volume · Oct 22 66.29K Avg daily vol (3M) 153.57K
All webcasts

Earnings call · FY2025 Q4

Lyell Immunopharma, Inc. (LYEL) Q4 2025 Earnings Call

Concluded Mar 12, 2026
Mar 12, 2026 0 turns
Period
FY2025 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $6,000 -45.5% YoY
Net income · derived Q4 -$140.72M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 12, 2026 10-K report Filed Mar 12, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

LYEL alerts

Lyell Immunopharma, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →